抗抑郁药使用与2型糖尿病风险的关联:日本一项大规模人群队列研究
该研究为日本大规模回顾性队列研究,纳入20-79岁抗抑郁药新使用者与非使用者,经倾向评分匹配后各45265例,共5225例(5.8%)发生糖尿病。抗抑郁药使用与糖尿病发病风险呈时间和剂量依赖性关联,调整后风险比短期低剂量为1.27(95%CI 1.16-1.39),长期高剂量为3.95(95%CI 3.31-4.72)。停药或减量后糖化血红蛋白水平降低(F[2,49]=8.17;P<0.001)。
要点
- 抗抑郁药使用与2型糖尿病发病风险呈时间和剂量依赖性关联。
- 调整后风险比:短期低剂量1.27(95%CI 1.16-1.39),长期高剂量3.95(95%CI 3.31-4.72)。
- 糖尿病发病后停药或减量者糖化血红蛋白水平较低(F[2,49]=8.17;P<0.001)。
核心结论
- 长期使用抗抑郁药以时间和剂量依赖的方式增加2型糖尿病发病风险。
- 糖尿病发病后停用抗抑郁药或减少剂量时,糖耐量改善。
研究设计与样本
- 日本大规模回顾性队列研究,纳入2006年4月1日至2015年5月31日期间20-79岁抗抑郁药新使用者(暴露组)和非使用者(非暴露组)。
- 排除有糖尿病史或接受抗糖尿病治疗的患者,采用倾向评分匹配调整协变量。
- 共90530名受试者,倾向评分匹配后暴露组和非暴露组各45265例。
主要发现
- 共有5225例患者(5.8%)发生糖尿病。
- 抗抑郁药使用与糖尿病发病风险呈时间和剂量依赖性关联。
- 调整后风险比:短期低剂量抗抑郁药使用为1.27(95%CI 1.16-1.39),长期高剂量使用为3.95(95%CI 3.31-4.72)。
- 停用或减少抗抑郁药剂量的患者糖化血红蛋白水平较低(F[2,49]=8.17;P<0.001)。
关键数值与推荐
- 短期低剂量抗抑郁药使用调整后风险比1.27(95%CI 1.16-1.39)。
- 长期高剂量抗抑郁药使用调整后风险比3.95(95%CI 3.31-4.72)。
- 停用或减量抗抑郁药者糖化血红蛋白水平比较F[2,49]=8.17;P<0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to reveal the associations between the risk of new-onset type 2 diabetes and the duration of antidepressant use and the antidepressant dose, and between antidepressant use after diabetes onset and clinical outcomes. RESEARCH DESIGN AND METHODS: In this large-scale retrospective cohort study in Japan, new users of antidepressants (exposure group) and nonusers (nonexposure group), aged 20-79 years, were included between 1 April 2006 and 31 May 2015. Patients with a history of diabetes or receipt of antidiabetes treatment were excluded. Covariates were adjusted by using propensity score matching; the associations were analyzed between risk of new-onset type 2 diabetes and the duration of antidepressant use/dose of antidepressant in the exposure and nonexposure groups by using Cox proportional hazards models. Changes in glycated hemoglobin (HbA1c) level were examined in groups with continuous use, discontinuation, or a reduction in the dose of antidepressants. RESULTS: Of 90,530 subjects, 45,265 were in both the exposure and the nonexposure group after propensity score matching; 5,225 patients (5.8%) developed diabetes. Antidepressant use was associated with the risk of diabetes onset in a time- and dose-dependent manner. The adjusted hazard ratio was 1.27 (95% CI 1.16-1.39) for short-term low-dose and 3.95 (95% CI 3.31-4.72) for long-term high-dose antidepressant use. HbA1c levels were lower in patients who discontinued or reduced the dose of antidepressants (F[2,49] = 8.17; P < 0.001). CONCLUSIONS: Long-term antidepressant use increased the risk of type 2 diabetes onset in a time- and dose-dependent manner. Glucose tolerance improved when antidepressants were discontinued or the dose was reduced after diabetes onset.
引用
- Miidera H, Enomoto M, Kitamura S, et al. Association Between the Use of Antidepressants and the Risk of Type 2 Diabetes: A Large, Population-Based Cohort Study in Japan. Diabetes Care. 2020. PMID: 32051242. doi:10.2337/dc19-1175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。